Analytic

HII Secures Air Force Contract to Enhance Information-Sharing Within Intelligence Alliance

Retrieved on: 
Tuesday, November 21, 2023

MCLEAN, Va., Nov. 21, 2023 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Mission Technologies division was awarded a three-year task order under the Analytical and Technical Services contract to provide information-sharing capabilities to the Five Eyes intelligence alliance comprised of the United States, Australia, Canada, New Zealand and the United Kingdom.

Key Points: 
  • MCLEAN, Va., Nov. 21, 2023 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Mission Technologies division was awarded a three-year task order under the Analytical and Technical Services contract to provide information-sharing capabilities to the Five Eyes intelligence alliance comprised of the United States, Australia, Canada, New Zealand and the United Kingdom.
  • The objective of the Pegasus task order, administered by the Secretary of the Air Force’s Concept, Development and Management Mission Partner Capability Office, is to provide email, phone, video and chat capabilities to enable seamless collaboration between Five Eyes warfighters at both a national and international level.
  • “Pegasus is an important capability that will help U.S. military forces and Five Eyes members with critical war planning and execution,” said Grant Hagen, president of Mission Technologies’ Cyber, Electronic Warfare and Space business group.
  • The work will be performed by HII, together with major subcontractor General Dynamics Information Technology, Inc.
    Pegasus is a component of the overall Mission Partner Capabilities Office portfolio of capabilities that support the Mission Partner Environment, which allows the U.S. military and its mission partners to communicate, collaborate and share information securely.

Wolters Kluwer's MediRegs launches new automated analytics solution

Retrieved on: 
Tuesday, November 28, 2023

NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Wolters Kluwer Legal and Regulatory U.S. has launched Analytical APIs within MediRegs, Wolters Kluwer's acclaimed healthcare coding, reimbursement, and compliance solution. The launch of this service enables healthcare revenue cycle, reimbursement, and audit professionals to use automated analytics to increase efficiencies and cash collections throughout the audit and appeals processes.

Key Points: 
  • Analytical APIs provide healthcare revenue cycle professionals with real-time access to MediRegs, saving time and increasing efficiency
    NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Wolters Kluwer Legal and Regulatory U.S. has launched Analytical APIs within MediRegs , Wolters Kluwer's acclaimed healthcare coding, reimbursement, and compliance solution.
  • The launch of this service enables healthcare revenue cycle, reimbursement, and audit professionals to use automated analytics to increase efficiencies and cash collections throughout the audit and appeals processes.
  • "As healthcare revenue cycle professionals face significant staff shortages and rapidly changing Medicare rates, it's important for our customers to stay up to date on regulatory requirements," said David Bartolone, Wolters Kluwer's VP and General Manager MediRegs.
  • With healthcare revenue cycle professionals experiencing increased operational challenges, Wolters Kluwer has launched the Analytical APIs as an extension of the MediRegs platform so users can streamline their workflow and meet cash goals.

PingCAP Positioned as a Leader in the 2023 SPARK Matrix for Translytical Data Platforms by Quadrant Knowledge Solutions

Retrieved on: 
Thursday, November 16, 2023

MIDDLETON, Mass., Nov. 16, 2023 /PRNewswire/ -- Quadrant Knowledge Solutions announced today that it has named PingCAP a 2023 technology leader in the SPARK Matrix™ analysis of the global translytical data platforms market.

Key Points: 
  • MIDDLETON, Mass., Nov. 16, 2023 /PRNewswire/ -- Quadrant Knowledge Solutions announced today that it has named PingCAP a 2023 technology leader in the SPARK Matrix™ analysis of the global translytical data platforms market.
  • The Quadrant Knowledge Solutions SPARK Matrix™ includes a detailed analysis of global translytical data platforms market dynamics, major trends, vendor landscape and competitive positioning analysis.
  • According to Sreejith PS, Analyst, Quadrant Knowledge Solutions: "PingCAP's TiDB is an open-source distributed database solution that supports translytical capabilities.
  • Max Liu, founder and CEO of PingCAP, said: "PingCAP's positioning as a Leader in the 2023 SPARK Matrix for Translytical Data Platforms, reflects our focus on flexibility, reliability, scalability and multiple deployment options.

PingCAP Positioned as a Leader in the 2023 SPARK Matrix for Translytical Data Platforms by Quadrant Knowledge Solutions

Retrieved on: 
Thursday, November 16, 2023

MIDDLETON, Mass., Nov. 16, 2023 /PRNewswire/ -- Quadrant Knowledge Solutions announced today that it has named PingCAP a 2023 technology leader in the SPARK Matrix™ analysis of the global translytical data platforms market.

Key Points: 
  • MIDDLETON, Mass., Nov. 16, 2023 /PRNewswire/ -- Quadrant Knowledge Solutions announced today that it has named PingCAP a 2023 technology leader in the SPARK Matrix™ analysis of the global translytical data platforms market.
  • The Quadrant Knowledge Solutions SPARK Matrix™ includes a detailed analysis of global translytical data platforms market dynamics, major trends, vendor landscape and competitive positioning analysis.
  • According to Sreejith PS, Analyst, Quadrant Knowledge Solutions: "PingCAP's TiDB is an open-source distributed database solution that supports translytical capabilities.
  • Max Liu, founder and CEO of PingCAP, said: "PingCAP's positioning as a Leader in the 2023 SPARK Matrix for Translytical Data Platforms, reflects our focus on flexibility, reliability, scalability and multiple deployment options.

Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer

Retrieved on: 
Tuesday, November 7, 2023

Chase as the Company’s Chief Science Officer (“CSO”).

Key Points: 
  • Chase as the Company’s Chief Science Officer (“CSO”).
  • Dr. Chase is a distinguished Research & Development (“R&D”) chemist and seasoned business professional with an impressive academic and industrial track record spanning over 25 years.
  • Optimi Health CEO Bill Ciprick conveyed his excitement regarding Dr. Chase's addition to the team, remarking, “Dr.
  • Optimi Health warmly welcomes both Dr. Chase and Ms. Ranger to the Optimi team and anticipates an era of remarkable scientific progress under their guidance.

Syantra Emerges from Stealth with AI Powered RNA-Based Immune Response Detection Liquid Biopsy Platform and Announces Rob Lozuk as CEO

Retrieved on: 
Wednesday, November 1, 2023

"We are thrilled to add an accomplished world-class executive to our leadership team to elevate our pivotal work in blood-based cancer detection.

Key Points: 
  • "We are thrilled to add an accomplished world-class executive to our leadership team to elevate our pivotal work in blood-based cancer detection.
  • "The existing early cancer detection liquid biopsy paradigm is not adequate, economical, or scalable.
  • Truly disruptive healthcare technologies are generational – and that's exactly what Syantra's liquid biopsy platform will become" states CEO of Syantra, Rob Lozuk, and adds, "I'm thrilled to be joining the Syantra team at this critical juncture in the liquid biopsy arena.
  • Our AI powered RNA-based liquid biopsy platform represents a revolution for the screening and detection modalities by measuring a key shift in the body's immune response that allows cancer to develop.

Elsevier Delivers Enriched Knowledge Network on Japan's Leading Research Evaluation Platform for Enhanced Evidence-Based Policymaking

Retrieved on: 
Monday, October 2, 2023

The platform is continuously enhancing and upgrading its analytic scope and capability in response to the evolving needs of Japan's scientific and research priorities.

Key Points: 
  • The platform is continuously enhancing and upgrading its analytic scope and capability in response to the evolving needs of Japan's scientific and research priorities.
  • Accessible to policy makers, research funders, university leaders and the public, e-CSTI analyzes the relationship between research input and output to assess the outcome and impact resulting from investments into researcher and university activities.
  • Provide stronger evidence regarding the research ecosystem, thereby enabling a more effective and transparent process for improved policymaking.
  • For example, using more comprehensive information to support the allocation of funding to future research activities.

Fifth Eye's AHI System: Detects shock, patient deterioration hours ahead of vital signs

Retrieved on: 
Tuesday, September 26, 2023

ANN ARBOR, Mich., Sept. 26, 2023 /PRNewswire/ -- Fifth Eye brings AHI System – the most advanced predictive patient monitoring technology available today – to HLTH 2023 in Las Vegas, October 8–11, 2023.

Key Points: 
  • ANN ARBOR, Mich., Sept. 26, 2023 /PRNewswire/ -- Fifth Eye brings AHI System – the most advanced predictive patient monitoring technology available today – to HLTH 2023 in Las Vegas, October 8–11, 2023.
  • Clinicians will get an up-close look at the latest release of the AHI (Analytic for Hemodynamic Instability) platform at Viosk 6916.
  • "There are lots of patient monitoring solutions on the market, but none are like AHI," said Fifth Eye CEO Andrew Malcolmson.
  • "AHI uses AI to interpret waveform signal variations to detect signs of patient deterioration that have until now been undetectable.

Labstat Inc. and Universal/Global Laboratory Services (GLS) Enter Partnership to Boost Testing Solutions for Tobacco/Nicotine Industry

Retrieved on: 
Tuesday, August 29, 2023

KITCHENER, ON, Aug. 29, 2023 /PRNewswire/ -- Labstat Inc., A Certified Group Company, has entered a strategic partnership with Global Laboratory Services, Inc. (GLS), a subsidiary of Universal Leaf Tobacco Company, Inc. This alliance aligns Labstat's cutting-edge capabilities with GLS's comprehensive testing services, enabling both companies to offer tobacco and nicotine manufacturers more robust and integrated testing solutions.

Key Points: 
  • This alliance aligns Labstat's cutting-edge capabilities with GLS's comprehensive testing services, enabling both companies to offer tobacco and nicotine manufacturers more robust and integrated testing solutions.
  • The Labstat Greensboro facility is set to commence operations in fall 2023, expanding services to include CPA testing in Dec 2023.
  • "Customers of GLS and Labstat will benefit immensely from the expanded range of services, helping them streamline their R&D and obtain critical data more efficiently."
  • Through this collaboration, GLS's customers will gain access to additional analytical capabilities and services through Labstat and Certified Group's extensive network of 30+ laboratories across North America.

Emerson Expands Automation Leadership With Agreement to Acquire Flexim

Retrieved on: 
Wednesday, August 16, 2023

ST. LOUIS, Aug. 16, 2023 /PRNewswire/ -- Emerson (NYSE: EMR) today announced a definitive agreement to acquire FLEXIM Flexible Industriemeßtechnik GmbH ("Flexim"), a global leader in clamp-on ultrasonic flow measurement for liquids, gases and steam.

Key Points: 
  • ST. LOUIS, Aug. 16, 2023 /PRNewswire/ -- Emerson (NYSE: EMR) today announced a definitive agreement to acquire FLEXIM Flexible Industriemeßtechnik GmbH ("Flexim"), a global leader in clamp-on ultrasonic flow measurement for liquids, gases and steam.
  • Headquartered in Berlin, Germany, Flexim brings highly differentiated, complementary technology and strong customer relationships to Emerson, with an installed base of more than 100,000 flowmeters, as well as approximately 450 employees.
  • Flexim provides highly accurate, low-maintenance clamp-on ultrasonic flow measurement technology for a broad range of attractive end markets, including chemical, water & wastewater, life sciences, food & beverage, and power generation.
  • The transaction will expand Emerson's automation portfolio and measurement capabilities, complementing its existing flow measurement positions in Coriolis, differential pressure, magmeter and vortex flow measurement.